Autopsy report · NCT00739219

Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)

“Study terminated due to lack of care guidelines in the protocol.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 8 months after it had already started.
• Ran for about 1 year 10 months before it stopped.
• 260 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Apieron

Sponsor type

Industry

Conditions

Asthma

Interventions

Apieron Insight eNO monitor

Participants

260

Sites

12

Countries

United States

Trials that died the same way

• Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM
  “The study was terminated due to lack of efficacy.” (83% match in meaning)
• A Study of LY3405105 in Participants With Advanced Cancer
  “The study was terminated for lack of sufficient efficacy.” (82% match in meaning)
• A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
  “This study was terminated due to a lack of efficacy.” (82% match in meaning)
• A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
  “This study was terminated due to lack of clinical activity and not due to safety reasons.” (81% match in meaning)
• Dasatinib in Polycythemia Vera
  “This study was terminated due to lack of efficacy.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.